Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 28 June 2018

Indication(s)

Lokelma is indicated for the treatment of hyperkalaemia in adult patients.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/004029
Orphan designation No
Date First Approved 22-03-2018
Type Medicinal product subject to medical prescription
Marketing authorisation holder AstraZeneca AB